BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Ovarian cancer AND KLK2, P20151, 3817, ENSG00000167751, MGC12201, hK2, KLK2A2 AND Treatment
17 results:

  • 1. Cryptotanshinone suppresses ovarian cancer via simultaneous inhibition of glycolysis and oxidative phosphorylation.
    Wang T; Zhang M; Khan M; Li J; Wu X; Ma T; Li Y
    Biomed Pharmacother; 2024 Jan; 170():115956. PubMed ID: 38039759
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. The effect of cuproptosis-relevant genes on the immune infiltration and metabolism of gynecological oncology by multiply analysis and experiments validation.
    Ran XM; Xiao H; Tang YX; Jin X; Tang X; Zhang J; Li H; Li YK; Tang ZZ
    Sci Rep; 2023 Nov; 13(1):19474. PubMed ID: 37945610
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. A comparative study of [
    Xi Y; Sun L; Che X; Huang X; Liu H; Wang Q; Meng H; Miao Y; Qu Q; Hai W; Li B; Feng W
    Eur J Nucl Med Mol Imaging; 2023 Jul; 50(9):2885-2898. PubMed ID: 37093313
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. MFAP2 aggravates tumor progression through activating FOXM1/β-catenin-mediated glycolysis in ovarian cancer.
    Zhao LQ; Sun W; Zhang P; Gao W; Fang CY; Zheng AW
    Kaohsiung J Med Sci; 2022 Aug; 38(8):772-780. PubMed ID: 35546486
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. An Experimentally Induced Mutation in the UBA Domain of p62 Changes the Sensitivity of Cisplatin by Up-Regulating hk2 Localisation on the Mitochondria and Increasing Mitophagy in A2780 ovarian cancer Cells.
    Yu S; Yan X; Tian R; Xu L; Zhao Y; Sun L; Su J
    Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33924293
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Long non-coding RNA LINC00504 regulates the Warburg effect in ovarian cancer through inhibition of miR-1244.
    Liu Y; He X; Chen Y; Cao D
    Mol Cell Biochem; 2020 Jan; 464(1-2):39-50. PubMed ID: 31691157
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Targeting Glutathione and Cystathionine β-Synthase in ovarian cancer treatment by Selenium-Chrysin Polyurea Dendrimer Nanoformulation.
    Santos I; Ramos C; Mendes C; Sequeira CO; Tomé CS; Fernandes DGH; Mota P; Pires RF; Urso D; Hipólito A; Antunes AMM; Vicente JB; Pereira SA; Bonifácio VDB; Nunes SC; Serpa J
    Nutrients; 2019 Oct; 11(10):. PubMed ID: 31635026
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Differential Expression Patterns of Glycolytic Enzymes and Mitochondria-Dependent Apoptosis in PCOS Patients with Endometrial Hyperplasia, an Early Hallmark of Endometrial cancer,
    Wang T; Zhang J; Hu M; Zhang Y; Cui P; Li X; Li J; Vestin E; Brännström M; Shao LR; Billig H
    Int J Biol Sci; 2019; 15(3):714-725. PubMed ID: 30745857
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. miR-603 targeted hexokinase-2 to inhibit the malignancy of ovarian cancer cells.
    Lu J; Wang L; Chen W; Wang Y; Zhen S; Chen H; Cheng J; Zhou Y; Li X; Zhao L
    Arch Biochem Biophys; 2019 Jan; 661():1-9. PubMed ID: 30365936
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Cryptotanshinone suppresses cell proliferation and glucose metabolism via STAT3/SIRT3 signaling pathway in ovarian cancer cells.
    Yang Y; Cao Y; Chen L; Liu F; Qi Z; Cheng X; Wang Z
    Cancer Med; 2018 Sep; 7(9):4610-4618. PubMed ID: 30094960
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Double-negative feedback interaction between DNA methyltransferase 3A and microRNA-145 in the Warburg effect of ovarian cancer cells.
    Zhang S; Pei M; Li Z; Li H; Liu Y; Li J
    Cancer Sci; 2018 Sep; 109(9):2734-2745. PubMed ID: 29993160
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Triptolide antagonized the cisplatin resistance in human ovarian cancer cell line A2780/CP70 via hsa-mir-6751.
    Wang R; Ma X; Su S; Liu Y
    Future Med Chem; 2018 Aug; 10(16):1947-1955. PubMed ID: 29966441
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. The in vitro renal cell toxicity of some unconventional anticancer phenanthroline-based platinum(II) complexes.
    Ng NS; Wu MJ; Myers SJ; Aldrich-Wright JR
    J Inorg Biochem; 2018 Feb; 179():97-106. PubMed ID: 29197671
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Ginsenoside 20(S)‑Rg3 inhibits the Warburg effect through STAT3 pathways in ovarian cancer cells.
    Li J; Liu T; Zhao L; Chen W; Hou H; Ye Z; Li X
    Int J Oncol; 2015 Feb; 46(2):775-81. PubMed ID: 25405516
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Imaging of treatment response to the combination of carboplatin and paclitaxel in human ovarian cancer xenograft tumors in mice using FDG and FLT PET.
    Munk Jensen M; Erichsen KD; Björkling F; Madsen J; Jensen PB; Sehested M; Højgaard L; Kjær A
    PLoS One; 2013; 8(12):e85126. PubMed ID: 24386456
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Kallikrein-related peptidases in prostate, breast, and ovarian cancers: from pathobiology to clinical relevance.
    Avgeris M; Mavridis K; Scorilas A
    Biol Chem; 2012 Apr; 393(5):301-17. PubMed ID: 22505514
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Breast cancer following radiotherapy and chemotherapy among young women with Hodgkin disease.
    Travis LB; Hill DA; Dores GM; Gospodarowicz M; van Leeuwen FE; Holowaty E; Glimelius B; Andersson M; Wiklund T; Lynch CF; Van't Veer MB; Glimelius I; Storm H; Pukkala E; Stovall M; Curtis R; Boice JD; Gilbert E
    JAMA; 2003 Jul; 290(4):465-75. PubMed ID: 12876089
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.